Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.72−0.03 (-1.71%)
Close on Nov 17, 2026Market cap $36.18MP/E –Yield –
Grace Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Grace Therapeutics's price to sales ratio was 0.4× on Jul 29, 2022.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 0.4× | −278.0 |
| 2021 | Jul 30, 2021 | 278.4× | – |
See a number that looks wrong?